Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-071472

Options or other derivatives

  • Chief Executive Officer acquired 936,444 shares (grant or award)
  • Chief Executive Officer returned 936,444 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Imran Talat · Chief Executive Officer

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2023-12-16 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −479,667 95,933 D
2023-12-16 Grant or award : show line 2 in the form Stock Option (Right to Buy) +479,667 479,667 D
2023-12-16 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −153,650 109,750 D
2023-12-16 Grant or award : show line 4 in the form Stock Option (Right to Buy) +153,650 153,650 D
2023-12-16 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −271,875 453,125 D
2023-12-16 Grant or award : show line 6 in the form 271875 +271,875 271,875 D
2023-12-16 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −31,252 47,699 D
2023-12-16 Grant or award : show line 8 in the form Stock Option (Right to Buy) +31,252 31,252 D
Loading xslF345X05/ownership.xml…